@RiskInhibitor Avatar @RiskInhibitor M

M posts on X about $upb, money, $avbp, $cntx the most. They currently have [--] followers and [--] posts still getting attention that total [-----] engagements in the last [--] hours.

Engagements: [-----] #

Engagements Line Chart

Mentions: [--] #

Mentions Line Chart

Followers: [--] #

Followers Line Chart

CreatorRank: [-------] #

CreatorRank Line Chart

Social Influence

Social category influence stocks 60% finance 16.67%

Social topic influence $upb #5, money 16.67%, $avbp #2, $cntx 10%, $artv 10%, $goss #3, $pepg #2, $sttk #1, $hims 6.67%, hims 6.67%

Top accounts mentioned or mentioned by @f1zzydrink1 @seedy19tron @balabioresearch @aaronrosenblum5 @lionswatson @riskinhibitornotep180221943r6vt2mcutmsourcenotesshareactionutmmediumweb @riskinhibitornotep180076857r6vt2mcutmsourcenotesshareactionutmmediumweb @blendedmelon @threadanddoc @octopusking77

Top assets mentioned Upstream Bio, Inc. (UPB) ArriVent BioPharma, Inc. (AVBP) Context Therapeutics Inc. (CNTX) Artiva Biotherapeutics, Inc. (ARTV) PepGen Inc. (PEPG) Shattuck Labs, Inc (STTK) Hims & Hers Health, Inc. (HIMS) Janux Therapeutics, Inc. (JANX) Kyverna Therapeutics, Inc. (KYTX) Evommune, Inc. (EVMN) Vir Biotechnology, Inc. Common Stock (VIR)

Top Social Posts

Top posts by engagements in the last [--] hours

"Its always wordcel vs shape rotator no one ever talks about the word rotators"
X Link 2026-02-03T23:33Z [--] followers, [--] engagements

"Bought more $AVBP shorting $GOSS keeping an eye on $PEPG $KYTX"
X Link 2026-02-13T17:13Z [--] followers, [----] engagements

"@seedy19tron What do you like about $CNTX"
X Link 2026-01-15T00:59Z [--] followers, [----] engagements

"$ARTV is such an obvious long at this price"
X Link 2026-01-25T21:56Z [--] followers, [---] engagements

"2026 longs and shorts im doing later for sure so far $ARTV L $AVBP L $STTK L $CYDY S"
X Link 2026-01-03T23:25Z [--] followers, [---] engagements

"Out of $EVMN long $EVMN short begins now. Holding $NKTR"
X Link 2026-02-10T14:36Z [--] followers, [---] engagements

"Long $PEPG into readout. Moderate sizing"
X Link 2026-02-10T18:14Z [--] followers, [---] engagements

"Re-entering $STTK very cheap relative to the TL1A assets"
X Link 2026-02-10T18:18Z [--] followers, [--] engagements

"long $UPB because my friends like it"
X Link 2026-02-11T00:34Z [--] followers, [---] engagements

"$UPB Tez efficacy with dosing 3-6x less frequent. Money"
X Link 2026-02-11T11:16Z [--] followers, [---] engagements

"RT @BalaBioResearch: paper out. working with adu has been an amazing experience. incredibly brilliant guy"
X Link 2026-02-15T13:46Z [--] followers, [--] engagements

"$HIMS is not about making money with the drugs themselves but about delivering maximum patient outcomes per $ spent in a way that others are increasingly unable to imitate. $HIMS is not about making money with the drugs themselves but about delivering maximum patient outcomes per $ spent in a way that others are increasingly unable to imitate. Think $HIMS is not about making money with the drugs themselves but about delivering maximum patient outcomes per $ spent in a way that others are increasingly unable to imitate. Think"
X Link 2025-10-19T00:02Z [--] followers, [---] engagements

"very long $AVBP"
X Link 2026-02-08T22:27Z [--] followers, [---] engagements

"I believe in their EDO delivery system. Strong mean splicing data at 15mg. Solid odds of efficacy. If positive they take the DM1 market"
X Link 2026-02-10T18:17Z [--] followers, [--] engagements

"EDO strongly mitigates ASO tox risk imo"
X Link 2026-02-10T18:19Z [--] followers, [--] engagements

"ED meds are lowkey erection SaaS or EaaS"
X Link 2026-02-10T23:44Z [--] followers, [--] engagements

"This is what friends are for. long $UPB because my friends like it long $UPB because my friends like it"
X Link 2026-02-11T11:10Z [--] followers, [---] engagements

"We make money together and we get bagged together This is what friends are for. This is what friends are for"
X Link 2026-02-11T17:24Z [--] followers, [---] engagements

"$UPB Tez efficacy with dosing 3-6x less frequent. Money. $UPB Tez efficacy with dosing 3-6x less frequent. Money"
X Link 2026-02-11T17:38Z [--] followers, [---] engagements

"$UPB march 15Ps saved me"
X Link 2026-02-12T20:27Z [--] followers, [---] engagements

"thanks @AaronRosenblum5 for making it clear its only down from here"
X Link 2026-02-12T20:47Z [--] followers, [---] engagements

"@f1zzydrink1 @LionsWatson No Im just correcting you"
X Link 2026-02-14T01:24Z [--] followers, [--] engagements

"this work of art ended up being meh and you think your favorite TCE-in-solid-tumor wont be Why what TCE problem does theirs cover that this doesn't "dosing regimen" lipstick on a pig. $CNTX $VIR $JANX"
X Link 2026-02-14T21:20Z [--] followers, [---] engagements

"After $GOSS short I will be full port $AVBP through readout"
X Link 2026-02-16T01:03Z [--] followers, [----] engagements

"$ARTV and $144510 👀"
X Link 2025-11-10T16:18Z [--] followers, [--] engagements

"$QNCX https://substack.com/@riskinhibitor/note/p-180221943r=6vt2mc&utm_source=notes-share-action&utm_medium=web https://substack.com/@riskinhibitor/note/p-180076857r=6vt2mc&utm_source=notes-share-action&utm_medium=web https://substack.com/@riskinhibitor/note/p-180221943r=6vt2mc&utm_source=notes-share-action&utm_medium=web https://substack.com/@riskinhibitor/note/p-180076857r=6vt2mc&utm_source=notes-share-action&utm_medium=web"
X Link 2025-11-29T03:57Z [--] followers, [--] engagements

"mfs will make crazy insights then convince themselves its already priced in lmfao"
X Link 2026-01-21T09:55Z [--] followers, [--] engagements

"$CNTX CAR-T TCE or NK cells in solid tumors. it never goes well. Have we learned nothing from $JANX Even with genius design TCEs don't work well in solid tumors. There are ZERO TCEs approved for solid tumors despite incessant attempts. Cell exhaustion dooms them all"
X Link 2026-01-10T09:07Z [--] followers, [---] engagements

"RT @RiskInhibitor: $HIMS is not about making money with the drugs themselves but about delivering maximum patient outcomes per $ spent in"
X Link 2026-02-07T02:37Z [--] followers, [--] engagements

"@blendedmelon 🫂I paid for the whole table before longing $ELDN"
X Link 2026-01-20T19:45Z [--] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing